thymus is of lpr/lpr or +/+ genotype. Conversely, a thymus of the lpr/lpr genotype does not confer early, severe SLE or lymphoproliferation to the +/+ mouse.
Materials and Methods
Mice. MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice originally developed by Murphy and Roths (1) were bred and maintained at the Scripps Mouse Colony, Scripps Clinic and Research Foundation, La Jolla, Calif. All mice used in these experiments were females. Experimental and control animals were housed identically and allowed standard laboratory food and water ad lib. Mice were followed daily for signs of disease, lymphadenopathy, and survival and were bled monthly by retroorbital sinus puncture for serologic examinations.
Thymectomy. The control, unmanipulated MRL/Mp-+/+ mice. Thymeetomy was performed through a small longitudinal incision over the sternum, and the thymus was withdrawn by a wire loop as described previously (8) . In transplanted animals, a whole thymus from a 1-mo old donor was grafted under the skin at the back of the neck of the recipient by using a 19-gauge needle (8) . Apart from histologic examinations, the absence or presence of a thymus in thymectomized and thymus-transplanted animals was judged at 3 mo of age by determining the frequency of Thy-l.2 + cells in peripheral blood, number of plaque-forming cells in spleens, and the titer of hemagglutinating antibodies 5 d after intravenous immunization with 2 × 108 sheep erythrocytes (SRBC)--a T dependent antigen. Additionally, proliferative responses to the T cell mitogens concanavalin A (Con A) and phytohemagglutinin (PHA) were examined in splenocytes of five mice from each of these groups. Representative results are shown in Table I . Mice that were considered incompletely thymectomized or not reconstituted (-20%) were discarded and not included in the results given below.
Histologic Studies. Unless otherwise indicated, mice were killed when moribund and then autopsied. Sections of thymuses, spleens, mesenteric and peripheral lymph nodes, and kidneys were fixed in Bouin's fluid and stained with hematoxylin and eosin and periodic aeid-Schiff stain. Severity of glomerulonephritis was graded from 0 to 4 + as described previously (2) .
Serologic Studies. Blood urea nitrogen (BUN) was determined by Azostix strips as recommended by the manufacturer (Ames Division, Miles Laboratories, Inc., Elkhart, Ind.). IgG was estimated by single radial immunodiffusion (9) . Anti-single-strand DNA (ssDNA) and antidouble-strand DNA (dsDNA) antibodies were measured by a modified Farr assay as described (10) . The modified Raji cell assay (2) was used for detecting immune complexes in murine sera. Serum retroviral envelope gp70 was measured by a radioimmunoassay (11) . Cellular Analyses. Spleen and lymph node cell preparations, total spleen and lymph node cell counting, cell viability determinations, and assessment of surface-Ig-bearing and Thy-l.2 alloantigen-bearing cells were done as before (12, 13) . Proliferative responses to Con A and PHA were assessed after incubation for 3 d of triplicate cultures containing 2 x 105 splenocytes in microtiter plates with 0.25 #g and 100 #1 each of the respective mitogens per culture; 0.5 #Ci of [3H]thymidine was added 18 h before harvesting. The frequency of polyclonal Igosecreting cells in splenocyte populations was determined by a reverse hemolytic plaque assay in which SRBC coated with rabbit anti-mouse IgM,tc were developed with a rabbit anti-mouse Ig and guinea pig complement (14) .
Results
Survival Rate. The median survival times (Fig. 1 ) of unmanipulated MRL/Mplpr/lpr and MRL/Mp-+/+ mice were 160 and 510 d, respectively. Of these control lpr/lpr mice, 100% developed grossly apparent lymphoid hyperplasia and dermatitis as previously described (1-3). The lymphoid hyperplasia became evident clinically when the animals were -3.5 mo of age and progressed thereafter until death. The lpr/lpr mice thymectomized and subsequently transplanted with +/+ thymuses retained the disease phenotype of the unmanipulated lpr/lpr mice, including lymph node hyperplasia and a 50% mortality at 186 d. The +/+ mice were similarly unchanged by thymectomy and transplation with lpr/lpr thymuses; these mice did not develop lymphoid hyperplasia and 50% remained alive at 498 d of age, which is not appreciably different than that of the unmanipulated controls. In contrast, lpr/lpr mice successfully thymectomized when newborn but not transplanted with thymuses did not develop lymph node hyperplasia or dermatitis, and 100% of them were alive by the 13 mo of age, a point well beyond the 90% death rate of control, unmanipulated L_ (25) lpr/lpr mice (9 mo of age). Of a total of 20 thymectomized, untransplanted animals, 10 mice in apparently good health and without lymphoid hyperplasia were killed at 13 mo of age for histologic and cellular studies (see below). The remaining 10 animals are still alive and under observation.
Histolic Observations. About 90% (Table II) Serologic Characteristics. Serologically, the lpr/lpr recipients of +/+ thymus and the +/+ recipients of lpr/lpr thymus behaved like the unmanipulated respective groups; hypergammaglobulinemia, high levels of anti-ssDNA and anti-dsDNA antibodies, retroviral gpT0, immune complexes, and BUN were observed in the former, but not the latter recipients (Table III) . However, thymectomized, untransplanted lpr/lpr mice had significantly reduced levels in each of these categories compared with unmanipulated controls (P <0.001, Student's t test).
Cellular Characteristics. As indicated above, thymectomized, untransplanted lpr/lpr mice did not develop the characteristic lymph node hyperplasia observed upon gross examination of their 4-5-mo old unmanipulated counterparts. Approximately 6 × 108-7 × 10 a cells were recoverable from mesenteric lymph nodes of a diseased 5-tooold unmanipulated lpr/lpr mouse or an lpr/lpr mouse thymectomized and transplanted with +/+ thymus, and -90% of these cells were Thy-1.2 antigen positive (Table IV) .
In comparison, successfully thymectomized, untransplanted lpr/lpr mice that were killed had mesenteric, inguinal, and submaxillary nodes similar in size to those in 
Relationship between the Thymus and Glomerulonephritis in MRL Mice
Degree of glomerulonephritis immunologically normal murine strains. That is, only 13 × 106 cells were recovered from isolated mesenteric nodes of such animals. Similarly, thymectomized, untransplanted lpr/lpr mice did not have the splenomegaly so commonly found in unmanipulated or +/+ thymus-transplanted 4-5-mo-old lpr/lpr animals. As shown in Table   IV , approximately threefold more mononuclear cells were recovered from spleens of unmanipulated or +/+-thymus transplanted mice than from thymectomized, untransplanted lpr/lpr mice. Moreover, in the splenocyte populations from thymectomized and, subsequently, +/+ thymus-transplanted as well as in unmanipulated lpr/lpr mice, ~70% of cells were positive for Thy-l.2 antigen compared with only 11% in thymectomized, untransplanted mice. Conversely, 4-/+ thymus-transplanted or unmanipulated lpr/lpr mice had 19-27% of surface Ig (sIg)-positive cells in their spleens, whereas thymectomized, untransplanted animals had 67% of similarly stained cells. Therefore, in absolute numbers, the spleens and mesenteric lymph nodes of unmanipulated or +/+ thymus-transplanted lpr/lpr mice had ~80-to 90-fold more T cells than those of thymectomized, untransplanted lpr/lpr mice. In addition, these thymectomized, untransplanted animals had ~ 10-fold less spontaneous Ig-secreting cells in their spleens than unmanipulated or +/+ thymus transplanted lpr/lpr mice (Table lpr/lpr thymus-transplanted +/+ mice.
Discussion
The important and novel point made by these studies pertains to the irrelevance of the thymus genotype to the phenotype of autoimmune disease in the MRL strain of mice. Our studies demonstrate that the thymus must be present for expression of lymphoid hyperplasia caused by T cell proliferation and for early SLE in the lpr/lpr phenotype of MRL/Mp mice but the genotype of the thymus is irrelevant. Conversely, these experiments demonstrate that differentiation of +/+ stem cells (from the congenic substrain) to T cells under the hormonal or microenvironmental influence of a thymus that possessess the lpr genotype does not lead to abnormal T cell differentiation and early autoimmunity. In addition, because early thymectomy improved survival of lpr/lpr mice, we may conclude that the B cell hyperactivity leading to the immune complex-mediated aspects of SLE was dependent upon the presence of a thymus and not exclusively caused by either an intrinsic B cell defect or mitogenic stimulation that causes polyclonal B cell activation. Our experiments have not established whether the T cell defect associated with the disease is acquired at the prethymic or thymic level. Nor have they determined whether the thymic effects necessary for expression of T cell proliferation are exerted within the thymic microenvironment or extrathymically via thymic hormones (15), or both. Nevertheless these experiments certainly exclude causation of the disease by intrinsic abnormalities of the lpr/lpr thymus (hormonal or microenvironmental) because the lpr/lpr early, severe SLE is not prevented or delayed by +/+ thymus and transplantation of lpr/lpr thymus to the +/+ mice does not cause T cell proliferation and early SLE in this substrain. After our initial report (i 6) and during the completion of our studies, others also reported inhibition of lymphoid hyperplasia and early disease development in neonatally thymectomized lpr/lpr mice (17) .
Several other observations indicate the importance of the lpr gene and of associated T cell proliferation in the development of early, severe SLE in MRL mice. We previously demonstrated that total lymphoid irradiation (TLI) or whole body irradiation of 3-mo-old lpr/lpr mice inhibited expression of lymphoid hyperplasia and the early appearance of disease (18) . Of interest, the beneficial effect of TLI was seen whether or not the thymus was shielded during irradiation (A. N. Theofilopoulos, B. L. Kotzin, and S. Strober, unpublished observation), suggesting that the primary defect might be in a radiosensitive prethymic precursor clone that needs the thymus to be expressed. The important role of the lpr gene in T cell proliferation, and consequently in the early SLE syndrome, has also been shown in genetic studies (1, 3, 16, 19 (20, 21) and others (22) when testing NZB backcross males bearing the xid gene and producing very little IgM or anti-DNA antibody.
In contrast to the beneficial effects of thymectomy in lpr/lpr mice, our unpublished studies and those of others indicate that neonatal thymectomy accelerated the disease of NZB/W mice, especially males (17, (23) (24) (25) . Moreover, athymic nude NZB/W mice developed disease at the same pace and as severely as their nu/+ controls (26) . All these findings suggest an intrinsic B cell defect or polyclonal B cell activators as the responsible agent of disease in NZ mice and questioned the primary importance of the reported hormonal (5) and cellular (7, 27) defects of the NZ thymus in the development of SLE in this strain of mice. These results highlight once again the complex pathogenesis of murine SLE and reinforce our earlier proposal (28) that the cause and course of this disease in the various strains may rest on individual basic defects, different pathways of abnormalities, and distinct accelerating factors. Such an acceleratong factor acting on a background of autoimmune disease that develops late in life may modify it to an early-life one (3, 16, 19) . The accelerating factors have now been defined as the lpr gene in MRL/Mp-lpr/lpr mice (I, 16-18; this study, and studies currently in progress), the Y chromosome-linked defect in BXSB male mice (1, 3, 16, 19, 29, 30) , and possibly hormonal influences in NZB/W mice (31) . As shown here, thymectomy blocked expression of the lpr accelerating factor and modified this disease of lpr/lpr substrain to a late disease or to no disease at all.
This study and studies underway strongly suggest that early, severe SLE-like disease in lpr/lpr mice is caused by abnormal stem cells, which upon differentiation in a thymus (irrespective of its genotype) give rise to proliferating Thy-l.2 +, Ly-1 ÷ cells (12, 32) that accelerate or help the expression of hypergammaglobulinemia, autoantibody production, and disease. This conclusion is consistent with results of previous studies suggesting that the proliferating cells in lpr/lpr mice exert an excessive helper function in vitro for polyclonal Ig synthesis (14) and anti-DNA antibody (33) production. Sequential studies remain to be performed so as to determine the exact onset of B cell hyperactivity in this substrain and its relationship to the expression of the lpr gene. In other words, it remains still to be ascertained whether expression of the lpr gene has simply an accelerating effect on a preexisting B cell defect or whether it represents the actual triggering signal for expression of B cell activation and autoantibody production. At any rate, this is certainly the first animal model in which a single genetic defect has such a profound effect on the development of generalized autoimmunity. Congenic strains currently developed with single-gene defects provide a superb framework for comparison with normal genes at the same locus, for studying their interrelationship with known genes that control immunoregulation, and for linking genetic and cellular abnormalities as a whole with autoimmunity.
Summary
In young adulthood, MRL/Mp-lpr/lpr mice develop a severe systemic lupus erythematosus (SLE)-like syndrome associated with massive T cell proliferation. The congenic MRL/Mp-+/+ mice lack the lpr gene and develop chronic SLE late in life.
We have exchanged thymic transplants between these substrains so as to determine the role of the thymus in the development of early, severe SLE and of lymphoproli- 
